World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
24889
World Ranking
12825
National Ranking
6556

Richard Sposto publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Richard Sposto sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 353 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Richard Sposto D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Richard Sposto sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Richard Sposto is affiliated with the University of Southern California in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on various subfields including Molecular Biology, Public Health, Environmental and Occupational Health, Genetics, Radiology, Nuclear Medicine and Imaging, and Hematology.

The scientist's work addresses several main research topics such as Acute Lymphoblastic Leukemia research, Radiation Dose and Imaging, Glioma Diagnosis and Treatment, Neuroblastoma Research and Treatments, Childhood Cancer Survivors' Quality of Life, Acute Myeloid Leukemia Research, and Cancer therapeutics and mechanisms.

Notable recent publications by Richard Sposto include:

  • "Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on 'Head Start' III: a multi-institutional, prospective clinical trial" (2020) published in Neuro-Oncology
  • "Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study" (2020) published in Clinical Cancer Research
  • "Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia" (2020) published in Leukemia
  • "Development of a Risk Model for Pediatric Hospital-Acquired Thrombosis: A Report from the Children's Hospital-Acquired Thrombosis Consortium" (2020) published in The Journal of Pediatrics
  • "Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium" (2022) published in American Journal of Hematology

Frequent coauthors contributing alongside Sposto include Jemily Malvar, Paul S. Gaynon, Alan S. Wayne, James A. Whitlock, and Eric S. Schafer.

Richard Sposto has published multiple articles in venues such as Blood, Radiation Research, Neuro-Oncology, Leukemia, and the American Journal of Hematology, reflecting consistent contributions to these scientific journals.

Best Publications

  • The genetic landscape of high-risk neuroblastoma

    Trevor J Pugh;Olena Morozova;Edward F Attiyeh;Edward F Attiyeh;Shahab Asgharzadeh;Shahab Asgharzadeh

  • Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

    Roger J. Packer;Amar Gajjar;Gilbert Vezina;Lucy Rorke-Adams

  • The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone

    Audrey E. Evans;R. Derek T. Jenkin;Richard Sposto;Jorge A. Ortega

  • Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

    Catherine Patte;Anne Auperin;Mary Gerrard;Jean Michon

  • Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease

    Cameron K. Tebbi;Wendy B. London;Debra Friedman;Doojduen Villaluna

  • The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial - A report from the Childrens Cancer Study Group

    R. Sposto;I. J. Ertel;R. D. T. Jenkin;C. P. Boesel

  • Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.

    James B. Nachman;Richard Sposto;Philip Herzog;Gerald S. Gilchrist

  • Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

    Mitchell S. Cairo;Mary Gerrard;Richard Sposto;Anne Auperin

  • Multiagent Chemotherapy and Deferred Radiotherapy in Infants With Malignant Brain Tumors: A Report From the Children’s Cancer Group

    J. Russell Geyer;Richard Sposto;Mark Jennings;James M. Boyett

  • Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group

    Joann L. Ater;Tianni Zhou;Emiko Holmes;Claire M. Mazewski

  • Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group.

    Patricia L. Robertson;Karin M. Muraszko;Emiko J. Holmes;Richard Sposto

  • Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages

    Liping Song;Shahab Asgharzadeh;Jill Salo;Kelly Engell

  • Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study

    Richard H. Ko;Lingyun Ji;Phillip Barnette;Bruce Bostrom

  • Expression of p53 and prognosis in children with malignant gliomas.

    Ian F. Pollack;Sydney D. Finkelstein;Jeffrey Woods;Judith Burnham

  • Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

    Susan G Kreissman;Robert C Seeger;Katherine K Matthay;Wendy B London;Wendy B London

  • Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma

    Shahab Asgharzadeh;Jill A. Salo;Lingyun Ji;André Oberthuer

  • Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols.

    Girish Dhall;Howard Grodman;Lingyun Ji;Stephen Sands

  • Prognostic Significance of Gene Expression Profiles of Metastatic Neuroblastomas Lacking MYCN Gene Amplification

    Shahab Asgharzadeh;Roger Pique-Regi;Richard Sposto;Hong Wang

  • Primary neurosurgery for pediatric low-grade gliomas: a prospective multi-institutional study from the Children's Oncology Group.

    Jeffrey H. Wisoff;Robert A. Sanford;Linda A. Heier;Richard Sposto

  • Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study

    Yoav H Messinger;Paul S Gaynon;Paul S Gaynon;Richard Sposto;Richard Sposto;Jeannette van der Giessen

Frequent Co-Authors

Jonathan L. Finlay
Jonathan L. Finlay Nationwide Children's Hospital
Robert C. Seeger
Robert C. Seeger Children's Hospital of Los Angeles
Paul S. Gaynon
Paul S. Gaynon University of Southern California
Mitchell S. Cairo
Mitchell S. Cairo New York Medical College
Hiroyuki Shimada
Hiroyuki Shimada Stanford University
Esther M. John
Esther M. John Stanford University
Theresa H.M. Keegan
Theresa H.M. Keegan University of California, Davis
Wendy B. London
Wendy B. London Harvard University
Anna T. Meadows
Anna T. Meadows Children's Hospital of Philadelphia
Elizabeth A. Raetz
Elizabeth A. Raetz New York University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can open many doors for those interested in pursuing a medical career in the USA. Several accredited programs let you learn at your own pace, making them ideal for working professionals or students with busy schedules.

If you are looking to advance your nursing career, consider the cheapest dnp programs. These Doctor of Nursing Practice degrees offer a flexible and affordable way to move into leadership or specialized clinical roles.

Those interested in pharmacy can enroll in online pharmacy programs. These programs are designed to prepare students for licensure and dynamic roles in today’s evolving healthcare environment.

The rise of technology in healthcare has also fueled demand for professionals with an online health information management degree. These degrees equip graduates with the skills to handle medical data, compliance, and health informatics.

For a quicker entry point into the healthcare field, you can consider certified medical billing and coding online courses. These short programs can lead to fast-growing jobs in hospitals, clinics, or insurance companies.

Best Scientists Citing Richard Sposto

Trending Scientists

Recently Published Articles